Skip to main content
. 2013 Dec 1;5(5):581–587. doi: 10.1111/jdi.12183

Figure 1.

image

The change of mean glycated hemoglobin (HbA1c; %) of the oral antidiabetic drug (OAD) group subgrouped by the number of prescribed OADs. 1OAD, monotherapy of any OAD; 2OADs, combination therapy with any two OADs; 3OADs, combination therapy with any three OADs; 4OADs, combination therapy with any four OADs.